Background: Parkinson's disease is a common disorder that becomes more prevalent with
advanced age. The cardinal features are related to dopamine deficiency, arising from loss of …

… pathogenesis of PD, therapeutics targeting mitochondria have been … targets for the
development of therapeutic approaches for treatment of PD. Here, we summarize reported …

… before we conclude with a discussion of the potential of NTFs as a therapeutic target in PD.
… it a more attractive therapeutic target in PD, one with the ability perhaps to target both motor (…

… models, the safety issue of these targets needs to be analyzed before entering into the
clinical trial phase. Moreover, the novel therapeutic targets discussed in the current review offer …

Parkinson's disease (PD) is the most common movement disorder and the second most common
neurodegenerative disease after Alzheimer's disease… an attractive target for therapeutic …

… both familial forms of the disease and animal models places … disease is currently without a
cure and most therapies target … in disease pathogenesis and as a potential therapeutic target …

Parkinson’s disease (PD) is a progressive and chronic neurodegenerative disorder,
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology and …

… in the etiopathology of Parkinson's disease (PD) and as a result new therapeutic targets for
… 2 (Nrf2), as a pharmacological target for neuroprotective therapy in PD. Data generated by …

… targets for PD and even other neurodegenerative diseases. A … and help to establish effective
therapeutic strategies. In this review, … therapeutic interventions targeting neuroinflammation. …

Complex molecular mechanisms underlying the pathogenesis of Parkinson's disease (PD)
are gradually being elucidated. Accumulating genetic evidence implicates dysfunction of …